Medicines Formulary

Medicines A–Z

L

Drug name	NICE TAs	Comments
Lat gel (unlicensed product)
Latanoprost eye drops		Specialist ophthalmologist recommendation
Latanoprost eye drops preservative free (monopost)		Specialist ophthalmogist recommendation. First line preservative free option. For use within license for those patients requiring a preservative free preparation.
Latanoprost with Timolol preservative free (Fixapost®)		Specialist recommendation
L-carnitine chewable tablet		NHSE commissioned.
L-carnitine injection		NHSE commissioned.
L-carnitine liquid		NHSE commissioned.
Leflunomide tablets		ESCA
Lenalidomide capsules	TA171 - Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy TA322 - Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality TA586 - Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib TA587 - Lenalidomide plus dexamethasone for previously untreated multiple myeloma TA627 - Lenalidomide with rituximab for previously treated follicular lymphoma TA680 - Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma
Lenograstim injection

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.